Filling Drug Discovery Niche, Penn Team Helps Move Alzheimer’s Drug Into Clinical Trials
In a layer cake of research labs nestled on separate floors in a remote corner of the Hospital of the University of Pennsylvania, a new use for an existing drug was uncovered. The drug, epothilone D (EpoD), stalled after original tests as a cancer treatment, but Perelman School of Medicine...
iPod-like Advances Changing the Face of Cardiac-Assist Technology
To celebrate February as American Heart Month, the News Blog is highlighting some of the latest heart-centric news and stories from all parts of Penn Medicine. This month marks the five-year anniversary of Penn Medicine’s first implantation of a temporary total artificial heart (TAH) in a patient suffering from end-stage...
Menopause, Hormones and Heart Disease: The Battle to Find the Lesser of Three Evils
To celebrate February as American Heart Month, the News Blog is highlighting some of the latest heart-centric news and stories from all parts of Penn Medicine. Hot flashes. Night sweats. Sleep disturbances. Mood swings. Irregular and racing hearts. These are all signs of menopause setting in, the time in a...
Women & Heart Disease – the Usual and Unusual Risk Suspects
To celebrate February as American Heart Month, the News Blog is highlighting some of the latest heart-centric news and stories from all parts of Penn Medicine. The flowers and cards have all been delivered. The chocolates were devoured and Cupid can now take his annual break. But just because Valentine’s...
Hybrid Neurologists Care for Crossover Neurodegenerative Diseases
For diseases historically considered in the domain of distinct neurological sub-specialties - movement disorders, neuromuscular conditions, and dementia - the steady increase in our understanding of their overlapping causes and symptoms, as well as their co-existence in the same individual, has led to a shift in how care is delivered. Physicians, nurse practitioners, therapists, and other care-team members are cross-training and collaborating more than ever.
Stretched to the Breaking Point
With this year’s Super Bowl setting a record for being the most-viewed show in U.S. television history, concussions – more technically, mild traumatic brain injury (TBI) – have probably been on many a mind this week. TBI has long been a leading cause of death and disability, with over 1.7 million cases in the US alone each year.
The Whole Enchilada: New Method for High-Res Brain Images
Magnetic resonance imaging (MRI) provides exquisite structural detail of the brain, for example, to detect tumors or relative size of regions. However, current MRI methods are not capable of imaging the distribution of neurotransmitters – the brain’s chemical messengers -- across the whole brain. A new Nature Medicine paper out this week from Perelman School of Medicine researchers led by Ravinder Reddy, PhD, professor of Radiology, describes a first-of-its-kind MRI technique (GluCEST) to measure glutamate concentration and local changes across the whole brain. The technique is based on chemical exchange effects of protons in water.
An Epilogue to a Protein Saga – But Not the Last Word
Every saga needs occasional updates. TDP-43 -- a protein important in gene expression that can undergo pathologic misfolding -- is no different. Earlier reports on the protein were outlined in a Penn Med news blog, which describes its pathology and genetics related to neurodegenerative disease. But now the field is maturing and researchers are linking TDP-43 to a well-established clinical area - the role of oxidative stress in the demise of nerve cells.
